Annual report [Section 13 and 15(d), not S-K Item 405]

Intangible Assets and Impairment of Long-Lived Assets - Schedule of Losses for the IP R&D Assets (Details)

v3.25.1
Intangible Assets and Impairment of Long-Lived Assets - Schedule of Losses for the IP R&D Assets (Details)
 12 Months Ended
Dec. 31, 2023
USD ($)
CBR Pharma IP R&D Assets [Member]  
Schedule of Losses for the IP R&D Assets [Line Items]  
Balance
Impairment of IP R&D assets
Balance
180 LP IP R&D Assets [Member]  
Schedule of Losses for the IP R&D Assets [Line Items]  
Balance 9,063,000
Impairment of IP R&D assets (9,063,000)
Balance
Consolidated IP R&D Assets [Member]  
Schedule of Losses for the IP R&D Assets [Line Items]  
Balance 9,063,000
Impairment of IP R&D assets (9,063,000)
Balance